K
v
ire
.com
←
Back
Night
Docs
Library
Critique
…
Author
Paul N. Durrington
also known as P Durrington, P N Durrington, P. DURRINGTON
University of Manchester · United Nations Industrial Development Organization · Steno Diabetes Centers · University of San Diego
About this author
Works
433
Cited by
36,395
h-index
84
i10
256
ORCID ↗
Top papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington, et al.
·
2004
·
The Lancet
↗ 3,784
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Authors/Task Force Members, Ian D. Graham, Dan Atar, et al.
·
2007
·
European Heart Journal
↗ 3,754
OA
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Authors/Task Force Members, Željko Reiner, Alberico L. Catapano, et al.
·
2011
·
European Heart Journal
↗ 3,540
OA
Paraoxonase and Atherosclerosis
Paul N. Durrington, Bharti Mackness, Mike Mackness
·
2001
·
Arteriosclerosis Thrombosis and Vascular Biology
↗ 814
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
S. Matthijs Boekholdt, Benoît J. Arsenault, Samia Mora, et al.
·
2012
·
JAMA
↗ 792
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jane Armitage, Colin Baigent, Elizabeth H Barnes, et al.
·
2019
·
The Lancet
↗ 780
OA
ESC/EAS Guidelines for the management of dyslipidaemias
Alberico L. Catapano, Željko Reiner, Guy De Backer, et al.
·
2011
·
Atherosclerosis
↗ 704
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
Sue Shackleton, David J. Lloyd, Stephen N.J. Jackson, et al.
·
2000
·
Nature Genetics
↗ 699
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
Lee Hooper, Rachel Thompson, Roger Harrison, et al.
·
2006
·
BMJ
↗ 680
OA
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
Michael I. Mackness, D. W. S. Harty, Deepak Bhatnagar, et al.
·
1991
·
Atherosclerosis
↗ 492
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
Philip J. Barter, Christie M. Ballantyne, Rafael Carmena, et al.
·
2006
·
Journal of Internal Medicine
↗ 470
OA
Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins
Michael I. Mackness, Bharti Mackness, Paul N. Durrington, et al.
·
1996
·
Current Opinion in Lipidology
↗ 446
Books
Preventive cardiology
1993
·
Taylor & Francis Group
Hyperlipidaemia
1989
·
Butterworth-Heinemann
Hyperlipidemia
2007
·
A Hodder Arnold Publication
Hyperlipidemia (Fast Facts)
2005
·
Not Avail
Preventive Cariology
2001
·
Taylor & Francis Group Plc
Preventive cardiology
2003
·
Martin Dunitz
Hyperlipidaemia
2000
·
Health Press Ltd.